Plasma inhibition of lymphocyte proliferation in nephrotic syndrome: correlation with hyperlipidemia.
Plasma-mediated inhibition of normal lymphoproliferation is an unexplained immunologic abnormality frequently observed in nephrotic syndrome. Since hyperlipidemia, also common in nephrotic syndrome, has been linked with in vitro and in vivo immunodeficiency in other diseases, we have quantitated plasma-mediated inhibition of lymphoproliferation and related it to the degree of hyperlipidemia in 19 patients with nephrotic syndrome. Fifteen patients were hyperlipidemic; the plasma of 9 of these 15 caused greater than 60% inhibition of antigen-specific proliferative responses of normal lymphocytes. None of the four normolipidemic plasmas, nor a hyperlipidemic plasma depleted of lipoproteins by ultracentrifugation, was inhibitory. A highly significant correlation between the degree of inhibition and the plasma triglyceride levels in patients with nephrotic syndrome was observed (P less than 0.001). The results suggest that elevated plasma lipids may be the cause of the plasma-mediated inhibition of lymphoproliferation in nephrotic syndrome.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000276:immunology*; D007108:Immune Tolerance; D007223:Infant; D008213:Lymphocyte Activation; D009404:Nephrotic Syndrome / Q000097:blood / Q000150:complications / Q000276:immunology*; D014280:Triglycerides / Q000097:blood
D014280:Triglycerides